Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
ECOG 0, 1, or 2
Pathologically confirmed Sarcoma, by biopsy or excision
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 8 weeks
Awards & highlights
Study Summary
This trial is testing if radiation therapy can change the amount of iron in a sarcoma tumor.
Who is the study for?
This trial is for adults with pathologically confirmed Sarcoma who are prescribed radiation therapy. They should be able to perform daily activities (ECOG 0, 1, or 2) and must consent to participate. Treatment should start within five weeks after surgery or biopsy.Check my eligibility
What is being tested?
The study is testing T2* MRI imaging on sarcoma tumors to see if radiation therapy affects the iron levels in these tumors. It's a small pilot study designed to explore this potential relationship.See study design
What are the potential side effects?
Since the intervention being studied is an imaging technique and not a drug, there are no direct side effects from T2* MRI itself; however, standard risks associated with MRIs apply.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can take care of myself and perform daily activities.
Select...
My sarcoma diagnosis was confirmed through a biopsy or surgery.
Select...
I am receiving radiation therapy as recommended by my doctor.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in ferric iron levels detected by T2* MRI
Secondary outcome measures
Change in ferrous iron levels detected by T2* MRI
Trial Design
1Treatment groups
Experimental Treatment
Group I: T2* ImagingExperimental Treatment1 Intervention
Participants undergo T2* MRI imaging before beginning their course of radiation therapy and then after completing radiation therapy, about 2 weeks before their surgery.
Find a Location
Who is running the clinical trial?
Bryan AllenLead Sponsor
3 Previous Clinical Trials
116 Total Patients Enrolled
Holden Comprehensive Cancer CenterOTHER
26 Previous Clinical Trials
762 Total Patients Enrolled
1 Trials studying Sarcoma
36 Patients Enrolled for Sarcoma
National Cancer Institute (NCI)NIH
13,703 Previous Clinical Trials
40,931,735 Total Patients Enrolled
455 Trials studying Sarcoma
230,514 Patients Enrolled for Sarcoma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can take care of myself and perform daily activities.I am under 18 years old.My sarcoma diagnosis was confirmed through a biopsy or surgery.I am receiving radiation therapy as recommended by my doctor.My treatment is scheduled to start no later than 5 weeks after my surgery or biopsy.
Research Study Groups:
This trial has the following groups:- Group 1: T2* Imaging
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research venture still seeking participants?
"The clinical trial is still recruiting, according to information available on clinicaltrials.gov. This research was inaugurated in September 2018 and underwent its most recent update in August 2022."
Answered by AI
What is the current number of participants enrolled in this investigation?
"Affirmative. According to clinicaltrials.gov, this experiment is currently recruiting individuals as of August 12th 2022. It was initially posted on September 18th 2018 and requires 15 volunteers from one site."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger